CVS Adds Four Board Members in Deal with Activist Hedge Fund
- CVS Health is expanding its board of directors, adding four new members after reaching an agreement with Glenview Capital Management, an activist investor.
- Larry Robbins, CEO of Glenview Capital, will join the CVS board along with Leslie Norwalk, Guy Sansone, and doug shulman.
- CVS said the decision followed productive talks with Glenview, a long-term investor.
CVS Health bolsters its board by appointing four new directors in a strategic move following an agreement with activist investor Glenview Capital Management. This expansion, bringing the total to 16 board members, sees Glenview Capital’s CEO, Larry Robbins, join the ranks, along with Leslie Norwalk, Guy Sansone, and Doug Shulman. The decision comes after “productive engagement,” as CVS seeks to enhance its integrated businesses. The strategic partnership underscores CVS’s commitment to long-term value creation, with the new directors set to serve on key committees. News Directory 3 is reporting on the details. Discover what’s next for CVS as it navigates the competitive healthcare landscape with this strengthened leadership team.
CVS Health Expands Board With Four New Directors
CVS Health is expanding its board of directors, adding four new members after reaching an agreement with Glenview Capital Management, an activist investor. the move increases the board to 16 directors.
Larry Robbins, CEO of Glenview Capital, will join the CVS board along with Leslie Norwalk, Guy Sansone, and doug shulman. Glenview Capital increased its CVS shares by 31% in the third quarter, acquiring 2.8 million shares.
CVS said the decision followed productive talks with Glenview, a long-term investor. The new directors will serve on key committees. Norwalk will join the health services committee, sansone the audit committee, and Shulman the management planning and development committee.
The agreement includes customary confidentiality and standstill provisions.
“In our discussions with the leadership at Glenview, we agreed that we can deliver greater value from our integrated businesses to all of our stakeholders,” said Roger Farah, CVS executive chairman of the board.
“We welcome the prospect to join the board, roll up our sleeves and lock arms with the board and leadership team to drive long-term, sustainable value,” Robbins said.
What’s next
The expanded board aims to leverage integrated businesses to deliver greater value to CVS Health stakeholders, focusing on long-term, sustainable growth and strategic initiatives in the competitive healthcare landscape.